tosufloxacin has been researched along with Pyuria in 1 studies
tosufloxacin: quinolone anti-infective agent; structure given in first source
tosufloxacin : A racemate comprising equimolar amounts of (R)- and (S)-tosufloxacin.
7-(3-aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid : A 1,8-naphthyridine derivative that is 4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid bearing additional 2,4-difluorophenyl, fluoro and 3-aminopyrrolidin-1-yl substituents at positions 1, 6 and 7 respectively.
Pyuria: The presence of white blood cells (LEUKOCYTES) in the urine. It is often associated with bacterial infections of the urinary tract. Pyuria without BACTERIURIA can be caused by TUBERCULOSIS, stones, or cancer.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tsuji, Y | 1 |
| Okamura, K | 1 |
| Miyake, K | 1 |
| Ito, H | 1 |
| Kinukawa, T | 1 |
| Otani, T | 1 |
| Narushima, M | 1 |
| Kanai, S | 1 |
| Takagi, Y | 1 |
| Murase, T | 1 |
1 trial available for tosufloxacin and Pyuria
| Article | Year |
|---|---|
[Antibiotic prophylaxis for transurethral resection of the prostate--comparison of oral administration therapy with intravenous administration therapy].
Topics: Administration, Oral; Aged; Anti-Infective Agents; Cefotiam; Fever; Fluoroquinolones; Humans; Inject | 1993 |